Careium Toekomstige groei
Future criteriumcontroles 3/6
Careium is forecast to grow earnings and revenue by 16.5% and 10.2% per annum respectively. EPS is expected to grow by 16.8% per annum. Return on equity is forecast to be 8.8% in 3 years.
Belangrijke informatie
16.5%
Groei van de winst
16.8%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 32.8% |
| Inkomstengroei | 10.2% |
| Toekomstig rendement op eigen vermogen | 8.8% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 27 Oct 2024 |
Recente toekomstige groei-updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 1,056 | 68 | 63 | 128 | 1 |
| 12/31/2025 | 964 | 56 | 63 | 125 | 1 |
| 12/31/2024 | 869 | 54 | 38 | 89 | 1 |
| 9/30/2024 | 841 | 43 | 56 | 112 | N/A |
| 6/30/2024 | 857 | 45 | 43 | 98 | N/A |
| 3/31/2024 | 841 | 46 | 50 | 103 | N/A |
| 12/31/2023 | 825 | 38 | 62 | 112 | N/A |
| 9/30/2023 | 821 | 40 | -27 | 25 | N/A |
| 6/30/2023 | 780 | 12 | -52 | 3 | N/A |
| 3/31/2023 | 741 | 14 | -63 | -5 | N/A |
| 12/31/2022 | 725 | -11 | -87 | -21 | N/A |
| 9/30/2022 | 691 | -21 | -19 | 45 | N/A |
| 6/30/2022 | 656 | -7 | -20 | 40 | N/A |
| 3/31/2022 | 628 | -19 | -44 | 17 | N/A |
| 12/31/2021 | 588 | 5 | -71 | -20 | N/A |
| 12/31/2020 | 524 | 19 | 3 | 44 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: CARE's forecast earnings growth (16.5% per year) is above the savings rate (1.1%).
Winst versus markt: CARE's earnings (16.5% per year) are forecast to grow faster than the Swedish market (15.7% per year).
Hoge groeiwinsten: CARE's earnings are forecast to grow, but not significantly.
Omzet versus markt: CARE's revenue (10.2% per year) is forecast to grow faster than the Swedish market (0.01% per year).
Hoge groei-inkomsten: CARE's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: CARE's Return on Equity is forecast to be low in 3 years time (8.8%).